Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives More Patent Grants and Notices of Allowance
Lexaria’s DehydraTECH™ drug delivery platform promotes healthier ingestion methods The company continues to leverage its technology in new areas Lexaria was recently granted new Australian patents and new notices of allowance Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a leader in enhancing the flavor, bouquet and gastro-intestinal delivery of edible cannabinoid consumer products. It has patents granted in the U.S. and Australia for applications of its DehydraTECH™ technology. Moreover, the company has many patents pending in over 40 nations. Lexaria Bioscience’s business strategy involves expanding the applicability of its technology within and beyond the cannabinoid sector. Recently upgraded to…